GPLD1 and neoplasm: Interestingly, despite an identical accumulation of TAT-modified PLD in tumors, the most avid formulation decorated with 200 TAT peptides repeatedly exhibited the least effective preparation, while administration resulted in a significantly higher manifestation of skin necrosis at the site of the tumor (Figure 10g).